Top-Rated StocksTop-RatedNYSE:CI The Cigna Group (CI) Stock Price, News & Analysis $353.49 -1.63 (-0.46%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$352.99â–Ľ$359.4650-Day Range$319.14â–Ľ$366.6452-Week Range$253.95â–Ľ$370.64Volume2.36 million shsAverage Volume1.54 million shsMarket Capitalization$100.42 billionP/E Ratio29.02Dividend Yield1.58%Price Target$384.86 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get The Cigna Group alerts: Email Address The Cigna Group MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside8.9% Upside$384.86 Price TargetShort InterestHealthy1.26% of Float Sold ShortDividend StrengthModerateBased on Four FactorsSustainability-0.19Upright™ Environmental ScoreNews Sentiment0.75Based on 17 Articles This WeekInsider TradingSelling Shares$3.10 M Sold Last QuarterProj. Earnings Growth11.51%From $28.50 to $31.78 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.69 out of 5 starsMedical Sector55th out of 910 stocksHospital & Medical Service Plans Industry5th out of 11 stocks 2.5 Analyst's Opinion Consensus RatingThe Cigna Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 13 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageThe Cigna Group has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about The Cigna Group's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.26% of the float of The Cigna Group has been sold short.Short Interest Ratio / Days to CoverThe Cigna Group has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in The Cigna Group has recently increased by 4.85%, indicating that investor sentiment is decreasing. Previous Next 2.5 Dividend Strength Dividend YieldThe Cigna Group pays a meaningful dividend of 1.55%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthThe Cigna Group does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of The Cigna Group is 45.98%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, The Cigna Group will have a dividend payout ratio of 17.62% next year. This indicates that The Cigna Group will be able to sustain or increase its dividend.Read more about The Cigna Group's dividend. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThe Cigna Group has received a 61.64% net impact score from Upright. The largest positive contribution comes from its "Societal infrastructure" impact, which is mostly driven by its "Health insurance services for groups", "Long term disability insurance services for groups", "General medical expense insurance for individuals", and "Long term disability insurance services for individuals" products. See details.Environmental SustainabilityThe Environmental Impact score for The Cigna Group is -0.19. Previous Next 2.6 News and Social Media Coverage News SentimentThe Cigna Group has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 17 news articles for The Cigna Group this week, compared to 14 articles on an average week.Search InterestOnly 10 people have searched for CI on MarketBeat in the last 30 days. This is a decrease of -55% compared to the previous 30 days.MarketBeat FollowsOnly 11 people have added The Cigna Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -15% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, The Cigna Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,095,820.00 in company stock.Percentage Held by InsidersOnly 0.60% of the stock of The Cigna Group is held by insiders.Percentage Held by Institutions86.99% of the stock of The Cigna Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about The Cigna Group's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for The Cigna Group are expected to grow by 11.51% in the coming year, from $28.50 to $31.78 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of The Cigna Group is 29.02, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 127.87.Price to Earnings Ratio vs. SectorThe P/E ratio of The Cigna Group is 29.02, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 115.64.Price to Earnings Growth RatioThe Cigna Group has a PEG Ratio of 1.10. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioThe Cigna Group has a P/B Ratio of 2.38. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about The Cigna Group's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. About The Cigna Group Stock (NYSE:CI)The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.Read More CI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CI Stock News HeadlinesSeptember 5 at 1:35 PM | marketbeat.comWhat is a blue chip company? Overview and examples (CI)A blue chip is a publicly traded, well-established, financially sound company. Learn more about blue chips with MarketBeat.August 22, 2024 | insidertrades.comWilliam J. Delaney III Sells 2,691 Shares of The Cigna Group (NYSE:CI) StockSeptember 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. August 7, 2024 | marketbeat.comMedical Technology Stock Benefits from Rising Acute Care Demand (CI)Medical and surgical products manufacturer Stryker Co. (NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry.September 6 at 6:16 PM | marketwatch.comCigna Group stock underperforms Friday when compared to competitorsSeptember 6 at 4:21 PM | 247wallst.comIf You Can Buy Only 1 Dividend Stock, Make It One of These 3 Income StarsSeptember 5 at 9:01 PM | stocknews.com3 Undervalued Healthcare Stocks With Strong Upside PotentialSeptember 5 at 6:00 AM | prnewswire.comEvernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next yearSeptember 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. September 5 at 1:00 AM | marketwatch.comCigna Group stock underperforms Wednesday when compared to competitors despite daily gainsAugust 29, 2024 | msn.comCigna Group Stock Flashing Renewed Technical StrengthAugust 28, 2024 | markets.businessinsider.comCelltrion USA Enters Into Deal With Express Scripts, Cigna Healthcare To Expand Access To ZYMFENTRAAugust 28, 2024 | prnewswire.comCelltrion USA partners with Express Scripts and Cigna Healthcare to expand access to ZYMFENTRA® (infliximab-dyyb), the first and only FDA-approved subcutaneous infliximab on their medical benefit formularyAugust 28, 2024 | bizjournals.comCigna, Dignity Health contract dispute negotiations extendedAugust 28, 2024 | americanbankingnews.comBrokers Set Expectations for The Cigna Group's Q3 2024 Earnings (NYSE:CI)August 27, 2024 | marketwatch.comCigna Group stock underperforms Tuesday when compared to competitorsAugust 26, 2024 | reuters.comCigna to remove AbbVie's Humira from some drug reimbursement lists next yearAugust 25, 2024 | msn.comBillionaire Lee Cooperman Says The Market Is Expensive But The Cigna Group (CI) Is CheapSee More Headlines Receive CI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for The Cigna Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 6/20 Dividend6/04/2024Dividend Payable6/20/2024Last Earnings8/01/2024Ex-Dividend for 9/19 Dividend9/04/2024Today9/07/2024Dividend Payable9/19/2024Next Earnings (Estimated)11/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Hospital & medical service plans Sub-IndustryManaged Health Care Current SymbolNYSE:CI CUSIP12550910 CIK701221 Webwww.cigna.com Phone(860) 226-6000Fax860-226-6741Employees72,500Year Founded1981Price Target and Rating Average Stock Price Target$384.86 High Stock Price Target$438.00 Low Stock Price Target$341.00 Potential Upside/Downside+8.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage15 Analysts Profitability EPS (Most Recent Fiscal Year)$12.18 Trailing P/E Ratio29.02 Forward P/E Ratio12.40 P/E Growth1.1Net Income$5.16 billion Net Margins1.70% Pretax Margin1.88% Return on Equity17.83% Return on Assets5.10% Debt Debt-to-Equity Ratio0.73 Current Ratio0.71 Quick Ratio0.71 Sales & Book Value Annual Sales$216.01 billion Price / Sales0.46 Cash Flow$35.00 per share Price / Cash Flow10.10 Book Value$148.55 per share Price / Book2.38Miscellaneous Outstanding Shares284,074,000Free Float282,370,000Market Cap$100.42 billion OptionableOptionable Beta0.52 Social Links 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. David Michael Cordani (Age 59)President, CEO & Chair of the Board Comp: $5.11MMr. Brian C. Evanko (Age 47)Executive VP, CFO and President & CEO for Cigna Healthcare Comp: $2.63MMs. Noelle K. Eder (Age 54)Executive VP & Global Chief Information Officer Comp: $1.93MMs. Nicole Susan Jones (Age 53)Executive VP, Chief Administrative Officer & General Counsel Comp: $1.89MMr. Eric Paul Palmer (Age 48)Executive Vice President of Enterprise Strategy Comp: $2.71MMs. Terese Mary Agoglia Hoeltzel CPASenior VP of Tax & Chief Accounting OfficerMr. Ralph GiacobbeSenior VP & Head of Investor RelationsKari Knight StevensExecutive VP, Chief Human Resources Officer & Corporate SecretaryMr. Jason D. Sadler (Age 55)President of International MArkets & President of International Health Cigna Healthcare Comp: $1.86MMr. Christopher DeRosa M.B.A.President of U.S. Government - Healthcare's Medicare & Individual & Family Plan (IFP) BusinessesMore ExecutivesKey CompetitorsElevance HealthNYSE:ELVHumanaNYSE:HUMCenteneNYSE:CNCMolina HealthcareNYSE:MOHUnitedHealth GroupNYSE:UNHView All CompetitorsInsiders & InstitutionsSanctuary Advisors LLCBought 39,199 shares on 9/5/2024Ownership: 0.014%Brown Financial AdvisorsBought 5,143 shares on 8/30/2024Ownership: 0.002%Kestra Investment Management LLCBought 1,329 shares on 8/28/2024Ownership: 0.000%Dana Investment Advisors Inc.Sold 132 shares on 8/27/2024Ownership: 0.011%KPP Advisory Services LLCBought 56 shares on 8/27/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions Should I Buy The Cigna Group Stock? CI Pros and Cons Explained Pros Here are some ways that investors could benefit from investing in The Cigna Group: The Cigna Group has received multiple upgraded ratings from analysts, including a "strong-buy" rating, indicating positive sentiment towards the company's performance and potential growth. Recent insider activity shows that company insiders have been selling shares, which could be interpreted as a sign of confidence in the company's future prospects. The stock price of The Cigna Group has shown resilience, trading up despite market fluctuations, suggesting investor confidence in the company's stability. Analysts have set a consensus price target of $379.06 for The Cigna Group, indicating potential for stock price appreciation based on market expectations. The company's financial metrics, such as a PE ratio of 27.71 and a PEG ratio of 1.06, are in line with industry standards, reflecting a solid financial position. Cons Investors should be bearish about investing in The Cigna Group for these reasons: Despite positive analyst ratings, there have been instances of insider selling, which could raise concerns about the company's future performance or internal outlook. The stock price of The Cigna Group has experienced fluctuations, indicating potential volatility in the market and uncertainty surrounding the company's future trajectory. While the company's financial metrics are in line with industry standards, a PE ratio of 27.71 may suggest that the stock is currently trading at a premium, potentially limiting immediate upside for investors. Market conditions and regulatory changes in the healthcare industry could impact The Cigna Group's operations and profitability, leading to potential challenges for investors. Investors should consider the debt-to-equity ratio of 0.75, which may indicate a moderate level of leverage that could pose risks in a changing economic environment. These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, August 22, 2024. Please send any questions or comments about these The Cigna Group pros and cons to contact@marketbeat.com. CI Stock Analysis - Frequently Asked Questions How have CI shares performed this year? The Cigna Group's stock was trading at $299.45 on January 1st, 2024. Since then, CI shares have increased by 18.0% and is now trading at $353.49. View the best growth stocks for 2024 here. How were The Cigna Group's earnings last quarter? The Cigna Group (NYSE:CI) announced its quarterly earnings data on Thursday, August, 1st. The health services provider reported $6.72 EPS for the quarter, topping analysts' consensus estimates of $6.42 by $0.30. The business's revenue for the quarter was up 24.6% compared to the same quarter last year. Read the conference call transcript. What is David Cordani's approval rating as The Cigna Group's CEO? 1,329 employees have rated The Cigna Group Chief Executive Officer David Cordani on Glassdoor.com. David Cordani has an approval rating of 91% among the company's employees. This puts David Cordani in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. Does The Cigna Group have any subsidiaries? The following companies are subsidiaries of The Cigna Group: Express Scripts Holding Company, Brighter, Zurich Insurance Middle East, Alegis Care, Firstassist Insurance Services Ltd, Cigna HealthSpring, Choicelinx, and more. Who are The Cigna Group's major shareholders? The Cigna Group's top institutional investors include Massachusetts Financial Services Co. MA (3.85%), Legal & General Group Plc (0.94%), Dimensional Fund Advisors LP (0.93%) and Bank of New York Mellon Corp (0.82%). Insiders that own company stock include David Cordani, Eric P Palmer, Brian C Evanko, Jason D Sadler, Michael W Triplett, Nicole S Jones, Donna F Zarcone, William J Delaney III, Noelle K Eder, Paul A Sanford, Cynthia Ryan, Elder Granger, Everett Neville and Hoeltzel Mary T Agoglia. View institutional ownership trends. How do I buy shares of The Cigna Group? Shares of CI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of The Cigna Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that The Cigna Group investors own include NVIDIA (NVDA), Walt Disney (DIS), Bank of America (BAC), Salesforce (CRM), Alibaba Group (BABA), CVS Health (CVS) and UnitedHealth Group (UNH). This page (NYSE:CI) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Cigna Group Please log in to your account or sign up in order to add this asset to your watchlist. Share The Cigna Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CI Stock Alerts